1-6
Review
Placental site trophoblastic tumor
Nadereh Behtash and Mojgan Karimi Zarchi
7-17
Review
Increasing protection after tamoxifen: insights from the extended adjuvant aromatase inhibitor trials
Carsten Rose
19-27
Original Paper
Cyclooxygenase-2 expression on ifosfamide-induced hemorrhagic cystitis in rats
Francisco Yuri Bulcao Macedo, Fátima Baltazar, Paulo Roberto Carvalho Almeida, Fábio Távora and Francisco Valdeci Ferreira, et al.
29-35
Original Paper
Retrospective quantification of background incidence and stage distribution of breast cancer for the mammography screening pilot project in Wiesbaden, Germany
Gisela Schott, Margrit Reichel, Hans Junkermann and Nikolaus Becker
37-44
Original Paper
Intraperitoneal chemotherapy with hydroxycamptothecin reduces peritoneal carcinomatosis: results of an experimental study
Peng-Cheng Li, Liang-Dong Chen, Fang Zheng and Yan Li
45-50
Original Paper
Cancer cell-derived IL-1α induces IL-8 release in endothelial cells
Jung-Hyo Rhim, Sin-Ae Kim, Ji-Eun Lee, Dong-Jo Kim and Hong Keun Chung, et al.
51-57
Original Paper
Supra-additive antitumor effect of sunitinib malate (SU11248, Sutent®) combined with docetaxel. A new therapeutic perspective in hormone refractory prostate cancer
O. Guérin, P. Formento, C. Lo Nigro, P. Hofman and J. L. Fischel, et al.
59-65
Original Paper
An increase in cell number at completion of therapy may develop as an indicator of early relapse
Quantification of circulating epithelial tumor cells (CETC) for monitoring of adjuvant therapy in breast cancer
Katharina Pachmann, Robert Dengler, Kurt Lobodasch, Frank Fröhlich and Torsten Kroll, et al.
67-73
Original Paper
Expression of aromatase and estrogen sulfotransferase in preinvasive and invasive breast cancer
G. Hudelist, P. Wülfing, C. Kersting, H. Burger and B. Mattsson, et al.
75-82
Original Paper
Cardiotoxicity of fluoropyrimidines in different schedules of administration: a prospective study
Christos Kosmas, Manolis S. Kallistratos, Petros Kopterides, John Syrios and Helias Skopelitis, et al.
83-91
Original Paper
Overexpression of myocyte enhancer factor 2 and histone hyperacetylation in hepatocellular carcinoma
XueLi Bai, LiHua Wu, TingBo Liang, ZhiQiang Liu and JunJian Li, et al.
93-100
Original Paper
CYP1A1, CYP2E1, GSTM1, GSTT1, EPHX1 exons 3 and 4, and NAT2 polymorphisms, smoking, consumption of alcohol and fruit and vegetables and risk of head and neck cancer
Stefania Boccia, Gabriella Cadoni, Fakhredin A. Sayed-Tabatabaei, Mariangela Volante and Dario Arzani, et al.
101-107
Original Paper
Ursolic acid inhibits the formation of aberrant crypt foci and affects colonic sphingomyelin hydrolyzing enzymes in azoxymethane-treated rats
David Andersson, Yajun Cheng and Rui-Dong Duan
109-114
Original Paper
Sulfotransferase 1A1 (SULT1A1)
polymorphism and susceptibility to primary brain tumors
F. Bardakci, S. Arslan, S. Bardakci, A. O. Binatli and M. Budak
115-118
Original Paper
An examination of the influence of patient race and ethnicity on expressed interest in learning about cancer clinical trials
Maurie Markman, Judy Petersen and Robert Montgomery